Atrial fibrillation: Risk is still not well controlled let alone ablated

Research output: Contribution to journalLetter

1 Citation (Scopus)
Original languageEnglish
Pages (from-to)1132-1134
JournalClinical Therapeutics
Volume36
Issue number9
DOIs
Publication statusPublished - 2014

Cite this

@article{086143a9034a48218d72ef37e7698ed0,
title = "Atrial fibrillation: Risk is still not well controlled let alone ablated",
author = "Peter Thompson and Hemal Weerasooriya",
year = "2014",
doi = "10.1016/j.clinthera.2014.08.009",
language = "English",
volume = "36",
pages = "1132--1134",
journal = "Clinical Therapeutics",
issn = "0149-2918",
publisher = "Excerpta Medica",
number = "9",

}

Atrial fibrillation: Risk is still not well controlled let alone ablated. / Thompson, Peter; Weerasooriya, Hemal.

In: Clinical Therapeutics, Vol. 36, No. 9, 2014, p. 1132-1134.

Research output: Contribution to journalLetter

TY - JOUR

T1 - Atrial fibrillation: Risk is still not well controlled let alone ablated

AU - Thompson, Peter

AU - Weerasooriya, Hemal

PY - 2014

Y1 - 2014

U2 - 10.1016/j.clinthera.2014.08.009

DO - 10.1016/j.clinthera.2014.08.009

M3 - Letter

VL - 36

SP - 1132

EP - 1134

JO - Clinical Therapeutics

JF - Clinical Therapeutics

SN - 0149-2918

IS - 9

ER -